All treatments that reduce serum insulin levels, whether weight loss due to lifestyle changes, bariatric surgery, metformin or thiazolidinedione, significantly diminish anovulation and hyperandrogenemia (31,32). This evidence concerns the gene INS and polycystic ovary syndrome.